Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Ibex Medical Analytics logo — Pioneering AI-based cancer diagnostics in pathology

Ibex Medical Analytics

Pioneering AI-based cancer diagnostics in pathology

Founded 2016 United States Brookline, United States 95 employees Series C Total: $118.10M AI, Analytics +3

General Information

Company Name Ibex Medical Analytics
Founded Year 2016
Location United States Brookline, United States
Founders / Decision Makers
Team member
Employees 95
Industries AI, Analytics, Biotechnology +2
Funding Stage Series C
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Usage Based, Tiered Pricing
Social

BounceWatch is an independent company data service, not affiliated with Ibex Medical Analytics. To contact Ibex Medical Analytics, visit ibex-ai.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Ibex Medical Analytics compare?

A PDF of Ibex Medical Analytics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Ibex Medical Analytics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Nov 03, 2026

Ibex Medical Analytics participated in #ESMO2026, sharing findings through a poster presentation.

Growth Metrics Nov 01, 2026

Ibex Breast HER2 AI increased pathologist diagnostic accuracy by 6.6% and patient identification by 16%.

Ibex Medical Analytics a competitor of yours? Have our desk watch it

About Ibex Medical Analytics

Ibex Medical Analytics is at the forefront of revolutionizing the field of pathology through its pioneering AI-based cancer diagnostics. Founded in 2016, the company addresses the increasing challenges faced by pathologists, who struggle with overwhelming workloads, higher cancer prevalence, and the growing complexity of diagnostics due to personalized medicine.

Utilizing cutting-edge artificial intelligence, Ibex has developed clinical-grade algorithms and digital workflows that match the accuracy of human pathologists. Their platform, which has proven effective in clinical studies, enhances the quality and efficiency of cancer diagnosis while reducing diagnostic errors and increasing productivity.

Headquartered in the United States, Ibex has established itself as the first-ever AI-powered cancer diagnostics platform widely used in routine clinical practices globally. In September 2023, the company secured a $55.00M Series C investment from notable investors, including Octopus Ventures, 83North, aMoon, Dell Technologies Capital, Planven Investments, and Sienna Investment Managers, solidifying its position as a leader in AI-driven healthcare innovation.

Business keywords: AI-based cancer diagnostics, pathology, clinical-grade algorithms, digital workflows, diagnostic accuracy, computer vision, digital pathology, oncology, deep learning, precision medicine, predictive analytics, urology, real-time quality control

Services & Products

AI-powered diagnostic solutions
Cancer detection in multiple tissue types
Biopharma clinical trials support
Translational research in drug development
Enhancing diagnostic workflows

Target Customers

Pathologists Healthcare systems Diagnostic solution providers Biopharma companies Physicians

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $55.00M 6
Octopus Ventures 83North aMoon
Octopus Ventures, 83North +4
01 Sep 2023
Grant £1.50M 1
NHS England
01 Mar 2023
Debt Financing $10.00M 1
Kreos Capital
Kreos Capital
01 Nov 2022
Series B $38.00M 4
Octopus Ventures 83North aMoon
Octopus Ventures, 83North +2
01 Mar 2021
Round Undisclosed -
01 Sep 2019
Series A $11.00M 4
83North aMoon Dell Technologies Capital
83North, aMoon +2
01 Mar 2019
Seed $2.60M -
01 Mar 2017

Ibex Medical Analytics Alternatives & Competitors

View All Alternatives
Ibex Medical Analytics vs
Aignostics
Aignostics Germany

AI-powered tissue analysis, validated by pathologists

Series B
106 employees
AI, Health Care
Compare Ibex Medical Analytics vs Aignostics
Ibex Medical Analytics vs
NovaScan
NovaScan United States

Easy to use ex vivo and in vivo cancer detection that provides instantaneous, highly accurate result...

Convertible Note
16 employees
Biotechnology, Health Care
Compare Ibex Medical Analytics vs NovaScan
Ibex Medical Analytics vs
Aiforia Technologies
Aiforia Technologies Finland

Translate images into data, discoveries, and diagnoses with deep learning AI for image analysis.

IPO
81 employees
AI, Biotechnology
Compare Ibex Medical Analytics vs Aiforia Technologies
Also compare with: Ibex Medical Analytics vs PathAI PathAI Ibex Medical Analytics vs Mindpeak Mindpeak View all alternatives

FAQ About Ibex Medical Analytics

Pioneering AI-based cancer diagnostics in pathology
Ibex Medical Analytics was founded in 2016.
Ibex Medical Analytics is headquartered in Brookline, United States.
Ibex Medical Analytics operates in AI, Analytics, Biotechnology, Health Care and Machine Learning. Its work centres on AI-based cancer diagnostics, pathology, clinical-grade algorithms and digital workflows. Its customers include Pathologists, Healthcare systems and Diagnostic solution providers.
Ibex Medical Analytics has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Usage Based and Tiered Pricing.
Ibex Medical Analytics has approximately 95 employees.
Ibex Medical Analytics has completed 7 funding rounds, raising a total of $118.10M. The latest funding stage is Series C.
Ibex Medical Analytics offers: AI-powered diagnostic solutions, Cancer detection in multiple tissue types, Biopharma clinical trials support, Translational research in drug development, Enhancing diagnostic workflows.
Top alternatives and competitors to Ibex Medical Analytics include Aignostics, NovaScan, Aiforia Technologies, PathAI, Tribun Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ibex Medical Analytics and Aignostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Ibex Medical Analytics, https://bouncewatch.com/company/ibex-medical-analytics, updated 6 November 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout